At the same time, the pleiotropic, neurotrophic and neuroprotective properties of GLP-1RAs are also obvious and, taking into account the ability to enhance the energy metabolism of neurons and optimize synaptic plasticity these beneficial effects position GLP-1RAs as potential agents modifying brain diseases [109, 110]
The human bias toward immediate comfort over distant benefit often prevails
More bloating and discomfort
"Eli Lilly's tirzepatide cuts heart failure risks, company says"
Anti-Obesity Drugs Market Segmentation Analysis By Type The segment with the highest market share was that of prescription drugs, with revenue accounting for roughly 86.0%, which is largely attributable to GLP-1 agents, such as semaglutide and tirzepatide outshining their weight loss counterparts, owing to their superior performance and prolonged use among people who have to take medication while dealing with comorbidities such as obesity